Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

756 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Oncogenic Calreticulin Induces Immune Escape by Stimulating TGF-β Expression and Regulatory T Cell Expansion in the Bone Marrow Microenvironment.
Schmidt D, Endres C, Hoefflin R, Andrieux G, Zwick M, Karantzelis N, Staehle HF, Vinnakota JM, Duquesne S, Mozaffari Jovein M, Pfeifer D, Becker H, Blazar BR, Zähringer A, Duyster J, Brummer T, Boerries M, Baumeister J, Shoumariyeh K, Li J, Green AR, Heidel FH, Tirosh I, Pahl HL, Leimkühler N, Köhler N, de Toledo MAS, Koschmieder S, Zeiser R. Schmidt D, et al. Among authors: de toledo mas. Cancer Res. 2024 Jun 17. doi: 10.1158/0008-5472.CAN-23-3553. Online ahead of print. Cancer Res. 2024. PMID: 38885318
Corrigendum to "MageC2 protein is upregulated by oncogenic activation of MAPK pathway and causes impairment of the p53 transactivation function" [Biochim. Biophys. Acta, Mol. Cell Res. vol. 1868 (Issue 3) (March 2021) 118918].
Pascucci FA, Ladelfa MF, Toledo MF, Escalada M, Suberbordes M, Monte M. Pascucci FA, et al. Among authors: toledo mf. Biochim Biophys Acta Mol Cell Res. 2024 Aug;1871(6):119767. doi: 10.1016/j.bbamcr.2024.119767. Epub 2024 Jun 3. Biochim Biophys Acta Mol Cell Res. 2024. PMID: 38833988 No abstract available.
Outpatient management of prolonged seizures and seizure clusters to prevent progression to a higher-level emergency: Consensus recommendations of an expert working group.
Pina-Garza JE, Chez M, Cloyd J, Hirsch LJ, Kälviäinen R, Klein P, Lagae L, Sankar R, Specchio N, Strzelczyk A, Toledo M, Trinka E. Pina-Garza JE, et al. Among authors: toledo m. Epileptic Disord. 2024 May 30. doi: 10.1002/epd2.20243. Online ahead of print. Epileptic Disord. 2024. PMID: 38813941
Early focal electroencephalogram and neuroimaging findings predict epilepsy development after aneurysmal subarachnoid hemorrhage.
Campos-Fernández D, Montes A, Thonon V, Sueiras M, Rodrigo-Gisbert M, Pasini F, Quintana M, López-Maza S, Fonseca E, Coscojuela P, Santafe M, Sánchez A, Arikan F, Gandara DF, Sala-Padró J, Falip M, López-Ojeda P, Gabarrós A, Toledo M, Santamarina E, Abraira L. Campos-Fernández D, et al. Among authors: toledo m. Epilepsy Behav. 2024 Jul;156:109841. doi: 10.1016/j.yebeh.2024.109841. Epub 2024 May 19. Epilepsy Behav. 2024. PMID: 38768551
Triheptanoin Did Not Show Benefit versus Placebo for the Treatment of Paroxysmal Movement Disorders in Glut1 Deficiency Syndrome: Results of a Randomized Phase 3 Study.
De Giorgis V, Bhatia KP, Boespflug-Tanguy O, Gras D, Marina AD, Desurkar A, Toledo M, Miller I, Rotstein M, Schneider SA, Tarquinio DC, Weber Y, Brandabur M, Mayhew J, Koutsoukos T, De Vivo DC. De Giorgis V, et al. Among authors: toledo m. Mov Disord. 2024 May 9. doi: 10.1002/mds.29822. Online ahead of print. Mov Disord. 2024. PMID: 38725190
Abatacept Pharmacokinetics and Exposure Response in Patients Hospitalized With COVID-19: A Secondary Analysis of the ACTIV-1 IM Randomized Clinical Trial.
Balevic SJ, Benjamin DK Jr, Powderly WG, Smith PB, Gonzalez D, McCarthy MW, Shaw LK, Lindsell CJ, Bozzette S, Williams D, Linas BP, Blamoun J, Javeri H, Hornik CP; ACTIV-1 IM Study Group. Balevic SJ, et al. JAMA Netw Open. 2024 Apr 1;7(4):e247615. doi: 10.1001/jamanetworkopen.2024.7615. JAMA Netw Open. 2024. PMID: 38662372 Free PMC article. Clinical Trial.
756 results